Earnings History Data for Silence Therapeutics Plc (SLN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Silence Therapeutics Plc

Silence Therapeutics plc focuses on the discovery, development and delivery of novel RNA therapeutics in hematology, cardiovascular and other rare and metabolic indications. The Company's product candidate consist SLN124 for the treatment of iron overload disorders; SLN360 for the cardiovascular disease with high lipoprotein and SLN500 for the treatment of complement-mediated diseases which are in clinical stage. Silence Therapeutics plc is based in London, the United Kingdom.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
13-03-2024 PM SLN Silence Therapeutics Plc 891.13 -0.47 -0.25 -0.46 Silence Therapeutics reports FY results
[3/13/2024 7:07 AM]
25.54 -0.36 
(-1.39%)
26.80 0.90 
(3.47%)
4.55 - 26.83 412,870 270,000 119,497
14-11-2023 PM SLN Silence Therapeutics 275.00 -0.28 -0.56 0.00 Silence Therapeutics GAAP EPS of -7.4p, revenue of £2.8M
[11/14/2023 9:05 AM]
9.24 0.23 
(2.55%)
0.0 0.0 
(0.00%)
4.55 - 17.99 13,252 40,000 0
16-08-2023 PM SLN Silence Therapeutics 183.00 -0.36 -0.59 0.00 Silence Therapeutics GAAP EPS of -9.60p, revenue of £9.1M
[8/16/2023 2:47 PM]
6.38 0.26 
(4.25%)
6.45 0.33 
(5.39%)
4.55 - 17.99 14,908 50,000 101
15-03-2023 PM 7:00 AM ET
(Mar 15)
SLN Silence Therapeutics Plc 1,340 -0.46 0.45 -0.42 Silence Therapeutics reports FY results
[3/15/2023 7:17 AM]
9.34 -0.32 
(-3.36%)
0.0 0.0 
(0.00%)
7.80 - 21.32 41,598 60,000 0
10-11-2022 PM Before the open
(Nov 10)
SLN Silence Therapeutics 438.00 -0.25 -0.60 0.00 Silence Therapeutics GAAP EPS of -£0.70 misses by £0.51, revenue of £3.3M
[11/10/2022 9:27 AM]
12.75 1.00 
(8.49%)
0.0 0.0 
(0.00%)
7.80 - 26.84 20,199 30,000 0
17-03-2022 PM 0:00 AM ET
(Mar 17)
SLN Silence Therapeutics Plc 493.82 -0.42 -0.62 0.00 Silence Therapeutics GAAP EPS of 44.30p, revenue of £12.41M
[3/17/2022 7:16 AM]
16.70 -0.30 
(-1.76%)
17.85 0.85 
(5.00%)
15.29 - 35.00 9,298 21,240 0